Carillon Tower Advisers’s Acceleron Pharma XLRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$73.6M	Buy	575,271 +350,125	+156%	+$41.1M	0.45%	65
2020 Q3	$25.3M	Sell	225,146 -444,321	-66%	-$44.2M	0.34%	96
2020 Q2	$63.8M	Buy	669,467 +233,843	+54%	+$22.5M	0.49%	66
2020 Q1	$36.6M	Sell	435,624 -222,016	-34%	-$17.3M	0.36%	95
2019 Q4	$34.9M	Hold	657,640	–	–	0.23%	152
2019 Q3	$26M	Hold	657,640	–	–	0.18%	202
2019 Q2	$27M	Hold	657,640	–	–	0.19%	203
2019 Q1	$30.6M	Hold	657,640	–	–	0.22%	172
2018 Q4	$28.6M	Hold	657,640	–	–	0.24%	164
2018 Q3	$37.6M	Hold	657,640	–	–	0.27%	148
2018 Q2	$31.9M	Sell	657,640 -285,204	-30%	-$10.4M	0.25%	145
2018 Q1	$36.9M	Hold	942,844	–	–	0.29%	113
2017 Q4	$40K	Buy	+942,844	New	+$35.4M	0.43%	80